Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about TAF15: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
| Gene Symbol | TAF15 |
| Full Name | TATA-Binding Protein Associated Factor 15 |
| Chromosome | 16p11.2 |
| Protein Type | Transcription Factor |
| Function | TAF15 contains an N-terminal transcriptional activation domain and a C-terminal RNA recognition motif (RRM) domain, allowing it to function in both transcription and RNA processing. |
| Primary Expression | most tissues with highest expression in: |
| Molecular Weight | 65 kDa |
| UniProt ID | Q92804 |
| NCBI Gene ID | 8148 |
| Ensembl ID | ENSG00000172660 |
| OMIM | 601679 |
| GeneCards | TAF15 |
| Human Protein Atlas | TAF15 |
| Associated Diseases | Als, Alzheimer, Amyotrophic Lateral Sclerosis, Anxiety, Dementia, Huntington |
| Interactions | FUS, HNRNPA2B1, HNRPU, NUCLEOLIN, HNRNPA1, DNA |
| KG Connections | 126 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
graph TD
TAF15["<b>TAF15</b>"]
Ms{"Ms"}
TAF15 -->|"expressed in"| Ms
Cancer{"Cancer"}
TAF15 -->|"expressed in"| Cancer
FUS["FUS"]
TAF15 -->|"associated with"| FUS
EWSR1["EWSR1"]
TAF15 -->|"associated with"| EWSR1
DDIT3["DDIT3"]
TAF15 -->|"associated with"| DDIT3
neurodegeneration["neurodegeneration"]
TAF15 -->|"implicated in"| neurodegeneration
style TAF15 fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Ftld-Fet | component_of | disease | 0.90 |
| neurons | expressed_in | cell_type | 0.70 |
| Ms | expressed_in | disease | 0.65 |
| Cancer | expressed_in | disease | 0.65 |
| Alzheimer | associated_with | disease | 0.65 |
| Dementia | associated_with | disease | 0.65 |
| Als | associated_with | disease | 0.65 |
| Als | activates | disease | 0.65 |
| Dementia | activates | disease | 0.65 |
| Amyotrophic Lateral Sclerosis | activates | disease | 0.65 |
| Aging | activates | disease | 0.65 |
| ALS | activates | disease | 0.65 |
| Als | inhibits | disease | 0.65 |
| Amyotrophic Lateral Sclerosis | associated_with | disease | 0.65 |
| Amyotrophic Lateral Sclerosis | regulates | disease | 0.65 |
| Huntington | regulates | disease | 0.65 |
| ALS | inhibits | disease | 0.65 |
| Anxiety | associated_with | disease | 0.65 |
| TAU | associated_with | entity | 0.60 |
| FUS | associated_with | gene | 0.60 |
| EWSR1 | associated_with | gene | 0.60 |
| DDIT3 | associated_with | gene | 0.60 |
| FUS | activates | gene | 0.60 |
| HNRNPA2B1 | inhibits | gene | 0.60 |
| HNRPU | inhibits | gene | 0.60 |
| NUCLEOLIN | inhibits | gene | 0.60 |
| HNRNPA1 | activates | gene | 0.60 |
| GAIN | associated_with | gene | 0.60 |
| HUNTINGTIN | regulates | gene | 0.60 |
| TDP-43 | associated_with | gene | 0.60 |
| FUS | transports | gene | 0.60 |
| TARDBP | associated_with | gene | 0.60 |
| VAPB | associated_with | gene | 0.60 |
| VCP | associated_with | gene | 0.60 |
| Tdp-43 | associated_with | pathway | 0.60 |
| DNA | interacts_with | gene | 0.60 |
| RNA | interacts_with | gene | 0.60 |
| RNA | expressed_in | gene | 0.60 |
| FTLD | associated_with | gene | 0.60 |
| Neuron | associated_with | cell_type | 0.60 |
| ALS | associated_with | gene | 0.60 |
| RNA | activates | gene | 0.60 |
| HUNTINGTON | regulates | gene | 0.60 |
| AMYLOID | associated_with | gene | 0.60 |
| ALZHEIMER | associated_with | gene | 0.60 |
| DEMENTIA | associated_with | gene | 0.60 |
| Dna Repair | interacts_with | pathway | 0.60 |
| DEMENTIA | activates | gene | 0.60 |
| AND | associated_with | gene | 0.60 |
| Actin | interacts_with | protein | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| FUS | associated_with | entity | 0.60 |
| UBIQUITIN | activates | gene | 0.60 |
| P62 | activates | gene | 0.60 |
| TDP-43 | associated_with | gene | 0.60 |
| HNRNPA2B1 | inhibits | gene | 0.60 |
| HNRPU | inhibits | gene | 0.60 |
| NUCLEOLIN | inhibits | gene | 0.60 |
| SRPK1 | inhibits | gene | 0.60 |
| FUS | transports | gene | 0.60 |
| GAIN | associated_with | gene | 0.60 |
| HNRNPA1 | activates | gene | 0.60 |
| FUS | regulates | gene | 0.60 |
| HUNTINGTIN | regulates | gene | 0.60 |
| FUS | implicated_in | gene | 0.60 |
| SRPK1 | interacts_with | gene | 0.60 |
| FUS | translocates_to | gene | 0.60 |
| ALS2 | associated_with | gene | 0.60 |
| ANG | associated_with | gene | 0.60 |
| DAO | associated_with | gene | 0.60 |
| DCTN1 | associated_with | gene | 0.60 |
| FIG4 | associated_with | gene | 0.60 |
| NEFH | associated_with | gene | 0.60 |
| OPTN | associated_with | gene | 0.60 |
| SETX | associated_with | gene | 0.60 |
| SPG11 | associated_with | gene | 0.60 |
| ALZHEIMER'S DISEASE | associated_with | gene | 0.60 |
| AND | associated_with | gene | 0.60 |
| FTLD | associated_with | gene | 0.60 |
| ALZHEIMER | associated_with | gene | 0.60 |
| AMYLOID | associated_with | gene | 0.60 |
| DEMENTIA | associated_with | gene | 0.60 |
| ALS | activates | gene | 0.60 |
| AND | activates | gene | 0.60 |
| FTLD | activates | gene | 0.60 |
| NEURODEGENERATIVE DISEASES | activates | gene | 0.60 |
| AMYOTROPHIC LATERAL SCLEROSIS | activates | gene | 0.60 |
| AMYLOID | activates | gene | 0.60 |
| DEMENTIA | activates | gene | 0.60 |
| DNA | interacts_with | gene | 0.60 |
| RNA | interacts_with | gene | 0.60 |
| AND | inhibits | gene | 0.60 |
| FTLD | transports | gene | 0.60 |
| RNA | transports | gene | 0.60 |
| AND | transports | gene | 0.60 |
| ANXIETY | associated_with | gene | 0.60 |
| AMYOTROPHIC LATERAL SCLEROSIS | associated_with | gene | 0.60 |
| RNA | activates | gene | 0.60 |
| GENETIC MUTATIONS | associated_with | gene | 0.60 |
| DNA | regulates | gene | 0.60 |
| AMYOTROPHIC LATERAL SCLEROSIS | regulates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||